Chronic Kidney Disease and Coronary Artery Disease: JACC State-of-the-Art Review

Sarnak MJ, Amann KU, Bangalore S, Cavalcante JL, Charytan DM, Craig JC, Gill JS, Hlatky MA, Jardine AG, Landmesser U, Newby LK, Herzog CA, Cheung M, Wheeler DC, Winkelmayer WC, Marwick TH, Banerjee D, Briguori C, Chang TI, Chen CL, deFilippi CR, Ding X, Ferro CJ, Gill J, Gössl M, Isbel NM, Ishii H, Jardine MJ, Kalra PA, Laufer G, Lentine KL, Lobdell K, Lok CE, London GM, Małyszko J, Mark PB, Nie Y, Parfrey PS, Pecoits-Filho R, Pilmore H, Qunibi WY, Raggi P, Rattazzi M, Rossignol P, Ruturi J, Sabanayagam C, Shanahan CM, Shroff GR, Shroff R, Webster AC, Weiner DE, Winther S, Wiseman AC, Yip A, Zarbock A, Marwan M (2019)

Publication Type: Journal article, Review article

Publication year: 2019

Journal

Journal of the American College of Cardiology Elsevier

Book Volume: 74

Pages Range: 1823-1838

Journal Issue: 14

DOI: 10.1016/j.jacc.2019.08.1017

Abstract

Chronic kidney disease (CKD) is a major risk factor for coronary artery disease (CAD). As well as their high prevalence of traditional CAD risk factors, such as diabetes and hypertension, persons with CKD are also exposed to other nontraditional, uremia-related cardiovascular disease risk factors, including inflammation, oxidative stress, and abnormal calcium-phosphorus metabolism. CKD and end-stage kidney disease not only increase the risk of CAD, but they also modify its clinical presentation and cardinal symptoms. Management of CAD is complicated in CKD patients, due to their likelihood of comorbid conditions and potential for side effects during interventions. This summary of the Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference on CAD and CKD (including end-stage kidney disease and transplant recipients) seeks to improve understanding of the epidemiology, pathophysiology, diagnosis, and treatment of CAD in CKD and to identify knowledge gaps, areas of controversy, and priorities for research.

Authors with CRIS profile

Kerstin Ute Amann Professur für Nephropathologie Mohamed Marwan Department of Medicine 2 – Cardiology and Angiology

Involved external institutions

Abbott Northwestern Hospital US United States (USA) (US) Tufts Medical Center US United States (USA) (US) New York University (NYU) US United States (USA) (US) Flinders University AU Australia (AU) Baker Idi Heart And Diabetes Institute AU Australia (AU) Kidney Disease: Improving Global Outcomes (KDIGO) BE Belgium (BE) University College London (UCL) GB United Kingdom (GB) Duke University Medical Center US United States (USA) (US) Baylor College of Medicine US United States (USA) (US) University of British Columbia CA Canada (CA) Charité - Universitätsmedizin Berlin DE Germany (DE) Hennepin County Medical Center US United States (USA) (US) University of Glasgow GB United Kingdom (GB) Stanford University US United States (USA) (US)

How to cite

APA:

Sarnak, M.J., Amann, K.U., Bangalore, S., Cavalcante, J.L., Charytan, D.M., Craig, J.C.,... Marwan, M. (2019). Chronic Kidney Disease and Coronary Artery Disease: JACC State-of-the-Art Review. Journal of the American College of Cardiology, 74(14), 1823-1838. https://doi.org/10.1016/j.jacc.2019.08.1017

MLA:

Sarnak, Mark J., et al. "Chronic Kidney Disease and Coronary Artery Disease: JACC State-of-the-Art Review." Journal of the American College of Cardiology 74.14 (2019): 1823-1838.

BibTeX: Download